GSK Latest Press Releases

-- October 20, 2026 --

Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB) Business Wire 7:58 PM

-- October 19, 2026 --

Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer Business Wire 6:18 PM

-- October 8, 2026 --

Viola Davis partners with GSK to educate adults 50 and older about their shingles risk PRNewswire 7:40 AM

-- August 24, 2026 --

CPE Media & Data Company: Lowest Level of International Venture Capital Funding - Canadian VC H1 2026 PRNewswire 1:06 PM

-- July 28, 2026 --

New survey reveals Canadians underestimate chronic hepatitis B and its link to liver cancer PRNewswire 7:00 AM

-- July 22, 2026 --

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer PRNewswire 1:59 PM

-- July 13, 2026 --

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL Business Wire 1:30 PM

-- June 24, 2026 --

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market Globe Newswire 8:30 AM

-- June 17, 2026 --

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) Business Wire 4:21 PM

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) Globe Newswire 12:36 PM

-- June 10, 2026 --

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL Business Wire 11:20 AM

-- June 9, 2026 --

Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates Globe Newswire 9:44 AM

Market Data Delayed 15 Minutes